Taro Pharma (TARO) Reports Q1 EPS of $2.42

Taro Pharma (NYSE: TARO) reported Q1 EPS of $2.42, versus $1.08 reported last year. Revenue for the quarter came in at $215.3 million, versus $130.3 million reported last year.

For earnings history and earnings-related data on Taro Pharma (TARO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15